A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa
Clinical trial NCT05459532 · COMPLETED
Trial details
- NCT number
- NCT05459532
- Sponsor
- University of Witwatersrand, South Africa
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2023-07-07
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.